The Impulse programme entrepreneurs taking AI and Robotics to a new level
3 July 2025
While most of us are still getting to grips with the wonders of artificial intelligence (AI), Cambridge University’s Impulse programme entrepreneurs are already working on top-tier advancements to take this transformative innovation to a new level. One of the standout participants in this year’s 2025 cohort is Dr Markus...
13 May 2025
Cellestial Health, a pioneering pharmaceutical development spin-out from the University of Cambridge, has closed a £515,000 pre-seed equity funding round to accelerate the development of novel therapeutics targeting astrocytes, an often-overlooked cell type in the brain, with the first indication of Parkinson’s disease...
© 2025 University of Cambridge